GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (OTCPK:SARTF) » Definitions » EV-to-FCF

Sartorius AG (Sartorius AG) EV-to-FCF : 149.06 (As of Apr. 28, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sartorius AG EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sartorius AG's Enterprise Value is $23,328 Mil. Sartorius AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $157 Mil. Therefore, Sartorius AG's EV-to-FCF for today is 149.06.

The historical rank and industry rank for Sartorius AG's EV-to-FCF or its related term are showing as below:

SARTF' s EV-to-FCF Range Over the Past 10 Years
Min: -88.19   Med: 95.46   Max: 917.31
Current: 150.8

During the past 13 years, the highest EV-to-FCF of Sartorius AG was 917.31. The lowest was -88.19. And the median was 95.46.

SARTF's EV-to-FCF is ranked worse than
90.24% of 369 companies
in the Medical Devices & Instruments industry
Industry Median: 26.55 vs SARTF: 150.80

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-28), Sartorius AG's stock price is $248.00. Sartorius AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $2.355. Therefore, Sartorius AG's PE Ratio for today is 105.31.


Sartorius AG EV-to-FCF Historical Data

The historical data trend for Sartorius AG's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG EV-to-FCF Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 87.41 95.09 77.93 122.39 80.77

Sartorius AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 136.17 102.38 110.32 80.77 166.13

Competitive Comparison of Sartorius AG's EV-to-FCF

For the Medical Instruments & Supplies subindustry, Sartorius AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Sartorius AG's EV-to-FCF falls into.



Sartorius AG EV-to-FCF Calculation

Sartorius AG's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=23327.768/156.504
=149.06

Sartorius AG's current Enterprise Value is $23,328 Mil.
Sartorius AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $157 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sartorius AG  (OTCPK:SARTF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Sartorius AG's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=248.00/2.355
=105.31

Sartorius AG's share price for today is $248.00.
Sartorius AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.355.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Sartorius AG EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Sartorius AG's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG (Sartorius AG) Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.